nifedipine has been researched along with imidapril in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Belz, GG; Breithaupt-Grögler, K; Meurer-Witt, B; Ungethüm, W | 1 |
| Horiuchi, M; Kouzuma, R; Mizuki, T; Morishita, T; Nakashima, Y; Nakata, S; Okazaki, M; Suda, O; Sumiyama-Fujinishi, A; Tasaki, H; Tsutsui, M; Yanagihara, N | 1 |
2 trial(s) available for nifedipine and imidapril
| Article | Year |
|---|---|
Pharmacokinetic and dynamic interactions of the angiotensin-converting enzyme inhibitor imidapril with hydrochlorothiazide, bisoprolol and nilvadipine.
Topics: Adrenergic beta-Antagonists; Adult; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Area Under Curve; Bisoprolol; Calcium Channel Blockers; Cross-Over Studies; Diuretics; Double-Blind Method; Drug Interactions; Hemodynamics; Humans; Hydrochlorothiazide; Imidazoles; Imidazolidines; Male; Nifedipine; Sodium Chloride Symporter Inhibitors | 2001 |
Long-term treatment with imidapril but not with nifedipine enhances plasma NOx concentration in patients with essential hypertension.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Bradykinin; Female; Humans; Hypertension; Imidazolidines; Male; Middle Aged; Nifedipine; Nitric Oxide; Time Factors | 2006 |
1 other study(ies) available for nifedipine and imidapril
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |